Chinese stocks close lower as innovative drug stocks surge on AI drug discovery deal
Chinese equities closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Morning session trading volume reached 1.24 trillion yuan. Innovative drug and CXO stocks surged after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. The automotive sector rose on GAC Group's planned equity acquisition from FAW. Agriculture and tourism stocks also gained. Separately, Huawei announced the Ascend 960 chip release moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary awaiting refresh
Summary awaiting refresh
Cross-source coverage
Reporting timeline
China Stocks Close Lower; Huawei Advances Ascend 960 Chip, Fed Hikes Rates
Chinese stocks closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Morning session turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous day. Sector rotation was rapid, with innovative drugs, agriculture, and automotive stocks active. Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hit daily limits in the pharmaceutical sector. Ankai Bus, Haima Automobile, and Zotye Auto led automotive gains. In agriculture, Jinjian Rice Industry and Dunhuang Seed hit daily limits. On the news front, Huawei's Wang Tao announced at Huawei Connect 2026 that the Ascend 960 chip release is moved up to Q1 2027, three quarters earlier than planned. The Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' phase, with wet-lab experiments being the bottleneck.
Read sourceChina Stocks Close Lower; Innovative Drug Stocks Surge on AI Drug Discovery News
Chinese equities closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks rallied strongly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved from narrative to clinical realization. The automotive sector saw sudden gains after GAC Group announced plans to acquire equity from FAW. Agricultural stocks rose following the release of a digital village development plan. The tourism sector also performed well on cultural tourism policy support. Meanwhile, Huawei's Rotating Chairman Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027. The Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks End Lower; AI Drug Discovery, Auto, Agriculture Sectors Active
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index falling 0.29%, and the ChiNext Index falling 0.12%. Combined trading volume reached 1.24 trillion yuan in the morning session. The innovative drug and CXO concept stocks surged, driven by GenScript Biotech's collaboration with Eli Lilly on an AI/machine learning drug discovery platform. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector saw unusual upward movements after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agricultural sector was active following the release of the 'Action Plan for High-Quality Development of Digital Villages (2026-2030)'. The tourism sector also performed well. In other news, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceShow 17 older updatesHide older updates
China Stocks Close Lower; Innovative Drugs, Auto, Agriculture Sectors Active
Chinese equities closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Half-day turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Sector rotation was rapid: innovative drug and CXO concept stocks strengthened after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved to the 'clinical realization' stage. The automotive sector surged after GAC Group announced plans to acquire equity from FAW Co., Ltd. Agriculture stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030) by Chinese regulators. The tourism sector also gained after the Ministry of Culture and Tourism issued its '15th Five-Year Plan.' Meanwhile, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027. The Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks End Mixed; AI Drug Discovery, Auto, Agriculture Sectors Rally; Huawei Chip News
Chinese equities closed slightly lower on September 17, with the Shanghai Composite down 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Trading volume reached 1.24 trillion yuan in the morning session. Innovative drug and CXO concepts surged after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has entered a 'clinical realization' stage, boosting demand for molecular validation. The automotive sector rose on news that GAC Group plans to acquire equity from FAW Co., Ltd. Agriculture stocks gained following the release of the Digital Villages Action Plan (2026-2030). Tourism stocks also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Separately, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points, its first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge on AI Deal, Auto and Agriculture Active
China's three major stock indices closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Half-day turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged collectively after GenScript Biotech announced a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved to the 'clinical realization' phase, boosting demand for molecular validation. The automotive sector saw unusual upward moves after GAC Group announced a plan to acquire equity from FAW Co., Ltd., making FAW its second-largest shareholder. Agricultural stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026–2030). Tourism stocks also performed well after the Ministry of Culture and Tourism issued its '15th Five-Year Plan.' On the downside, precious metals concepts adjusted. In other news, Huawei's Wang Tao announced the Ascend 960 chip release moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks End Mixed; Drug, Auto, Agriculture Sectors Active; Fed Hikes Rates
Chinese equities fluctuated and consolidated in the morning session, with all three major indices closing slightly lower. The Shanghai Composite fell 0.36%, the Shenzhen Component fell 0.29%, and the ChiNext fell 0.12%. Trading volume reached 1.24 trillion yuan, up 79.5 billion from the previous session. Innovative drug and CXO concept stocks surged, driven by GenScript's collaboration with Eli Lilly's AI drug discovery platform and Zheshang Securities' view that AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector saw unusual upward moves after GAC Group announced plans to acquire a stake in a joint venture from FAW Co., Ltd., making FAW its second-largest shareholder. Agriculture stocks rose following the release of a digital village development plan. The tourism sector also performed well. Meanwhile, the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023. Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks End Mixed; Innovative Drug Stocks Surge on AI Drug Discovery News
Chinese equities closed mixed on September 17, with the Shanghai Composite Index down 0.36%, the Shenzhen Component Index down 0.29%, and the ChiNext Index down 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged after GenScript Biotech announced a collaboration with Eli Lilly on its AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' stage, and efficiency improvements will stimulate demand for molecular validation. The automotive sector saw unusual upward movements after GAC Group announced plans to acquire equity in a joint venture from FAW Co., Ltd. The agricultural sector was active following the release of a digital village action plan. The tourism sector also performed well. The Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023. Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge; Huawei Advances Ascend 960 Chip to 2027
Chinese equities closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Half-day trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the prior session. Sector rotation was rapid: innovative drug and CXO stocks surged after GenScript Biotech announced a collaboration with Eli Lilly on an AI drug discovery platform. Zheshang Securities commented that AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector rose following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. Agriculture stocks gained after China issued a digital village development plan. Tourism stocks also performed well. In technology, Huawei's rotating chairman Wang Tao announced at Huawei Connect 2026 that the Ascend 960 chip release is moved up to Q1 2027, with doubled performance. Separately, the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drug Stocks Surge on AI Drug Discovery News
Chinese equities closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Sector rotation was rapid, with innovative drug and CXO stocks surging after GenScript Biotech announced a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved from the 'algorithm narrative' phase to the 'clinical realization' stage. The automotive sector saw sudden gains after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agricultural sector rose following the release of a digital village development plan. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Meanwhile, the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023. Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks End Mixed; Innovative Drugs Surge on AI Drug Discovery News, Auto and Agriculture Active
China's three major stock indices closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index losing 0.12%. Half-day trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. The innovative drug and CXO sectors surged after GenScript Biotech announced a collaboration with Eli Lilly on its AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has entered the 'clinical realization' phase. The automotive sector saw sudden gains following GAC Group's announcement of a share acquisition plan involving FAW Co., Ltd. The agricultural sector was active after the release of a government action plan for digital village development. The tourism sector also performed well. Market hotspots rotated rapidly, with over 3,100 stocks declining. The technology sector showed internal divergence after leading gains the previous day. Separately, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge, Auto and Agriculture Sectors Active
Chinese stock markets closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan in the first half of the day, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks rallied broadly following GenScript Biotech's collaboration announcement with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved from the 'algorithm narrative' phase to the 'clinical realization' stage. The automotive sector saw unusual upward movements after GAC Group announced plans to acquire equity from FAW Co., Ltd. in a joint venture. The agriculture sector remained active following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030) by Chinese authorities. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Meanwhile, the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, its first hike since July 2023. Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks Close Lower; Innovative Drug Stocks Surge on AI Drug Discovery News
Chinese equities closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index down 0.29%, and the ChiNext Index down 0.12%. Turnover reached 1.24 trillion yuan in the morning session. Innovative drug and CXO stocks surged after GenScript Biotech announced a collaboration with Eli Lilly on its AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' phase, and efficiency improvements will stimulate demand for molecular validation. The automotive sector rose after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agricultural sector gained following the release of China's 'Action Plan for High-Quality Development of Digital Villages (2026–2030).' The tourism sector also performed well. Separately, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge, Auto and Agriculture Active
Chinese stock markets ended the morning session slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Over 3,100 stocks declined. Sector rotation was rapid: innovative drug and CXO concepts surged after GenScript announced a collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab, with Zheshang Securities stating AI-driven drug development has moved to 'clinical realization.' The automotive sector saw unusual upward moves after GAC Group announced plans to acquire equity from FAW Co., Ltd. in a joint venture. Agriculture stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030) by Chinese regulators. Tourism stocks also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Precious metals concepts fell. Separately, Huawei's Wang Tao announced the Ascend 960 chip release moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%.
Read sourceChina Stocks End Mixed; Innovative Drugs Surge on AI Drug Discovery, Auto and Agriculture Active
Chinese equities closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Turnover reached 1.24 trillion yuan in the morning session. Innovative drug and CXO stocks surged after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has entered the 'clinical realization' stage, boosting demand for molecular validation. The automotive sector rose on news of GAC Group's planned equity acquisition from FAW Co., Ltd. Agriculture stocks gained following the release of China's Digital Village Development Action Plan (2026-2030). Tourism stocks also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. The Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023. Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge on AI Drug Discovery News, Huawei Chip Release Advanced
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined morning trading volume reached 1.24 trillion yuan. Innovative drug and CXO concept stocks rallied broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved to the 'clinical realization' stage. The automotive sector saw unusual upward moves following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. The agricultural sector was active after the release of a digital village development plan. Separately, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%.
Read sourceChina Stocks Close Lower; AI Drug Discovery, Auto, Agriculture Sectors Active
China's three major stock indices closed slightly lower on September 17 after a morning session of volatile consolidation, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan in the first half, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks rallied broadly after GenScript Biotech announced a collaboration with Eli Lilly on its AI/machine learning drug discovery platform. Zheshang Securities commented that AI-driven drug discovery has moved to the 'clinical realization' stage, with efficiency gains spurring demand for molecular validation. The automotive sector saw unusual upward moves after GAC Group announced plans to acquire equity in a joint venture from FAW Co., Ltd., making FAW its second-largest shareholder. Agricultural stocks rose following the release of a national digital village development plan. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Over 3,100 stocks declined across the market, with precious metals concepts falling. The Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks End Lower; Innovative Drugs, Autos, Agriculture Gain; Fed Hikes
Chinese equities closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Morning session trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous day. Sector rotation was rapid: innovative drug and CXO concepts surged after GenScript announced a collaboration with Eli Lilly on an AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved to the 'clinical realization' stage. The automotive sector rose on news that GAC Group plans to acquire equity from FAW Co., Ltd., making FAW its second-largest shareholder. Agriculture stocks gained following a government action plan for digital village development. Tourism stocks also performed well after the Ministry of Culture and Tourism issued a five-year development plan. On the downside, precious metals concepts fell. Separately, Huawei's Wang Tao announced the Ascend 960 chip release is moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks End Mixed; AI Drug Discovery, Auto, Agriculture Sectors Lead Gains
China's three major stock indices closed slightly lower on September 17 after fluctuating in the morning session, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO stocks surged, driven by GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has entered a 'clinical realization' phase, boosting demand for molecular validation. The automotive sector rose on news of GAC Group's plan to acquire equity from FAW Co., Ltd. The agriculture sector gained after China issued a digital village development plan. The tourism sector also performed well following a cultural tourism plan. Market hotspots rotated rapidly, with over 3,100 stocks declining. Analysts noted a slow recovery in market sentiment and advised focusing on structural opportunities.
Read sourceChina Stocks End Lower; Drug, Auto, Ag Sectors Active; Fed Hikes; Huawei Chip News
Chinese equities closed slightly lower on September 17, with the Shanghai Composite down 0.36%, the Shenzhen Component down 0.29%, and the ChiNext down 0.12%. Turnover reached 1.24 trillion yuan. Innovative drug and CXO concept stocks rallied after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved to clinical realization. The automotive sector surged on news that GAC Group plans to acquire equity from FAW Co., Ltd. Agriculture stocks rose following a government digital village action plan. Tourism stocks also gained on a cultural tourism plan. Separately, Huawei's Wang Tao announced the Ascend 960 chip release is moved up to Q1 2027. The Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read source